China Pharma Holdings, Inc.CPHINYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank20
3Y CAGR-21.1%
5Y CAGR-24.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-21.1%/yr
vs +1.9%/yr prior
5Y CAGR
-24.7%/yr
Recent acceleration
Acceleration
-23.0pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $91407.00 | -67.8% |
| 2024 | $283942.00 | +18.3% |
| 2023 | $240080.00 | +29.2% |
| 2022 | $185858.00 | -41.7% |
| 2021 | $318964.00 | -15.6% |
| 2020 | $377964.00 | +64.6% |
| 2019 | $229637.00 | +33.2% |
| 2018 | $172384.00 | +90.5% |
| 2017 | $90474.00 | -75.3% |
| 2016 | $365969.00 | - |